GaudiClinical is a company to provide cell culture processing service, collectmedical data, and support regulatory compliance and other related workregulated under the Act on the Safety of Regenerative Medicine (RM Act) inJapan. Its mission is to contribute to improved QOL by providing regenerativemedicine such as repairing and improving the function of joint diseasedtissues.
Company name
Gaudi Clinical Inc.
Type of business
Healthcare
Representatives
Morikuni Morita
Establishing a company
June 2021
Investment announcement date
February 2025
Capitalist
Mayumi Beppu
HP
https://gaudi-clinical.co.jp/Phasing
Early